290 related articles for article (PubMed ID: 19950555)
1. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
2. [31P-MR spectroscopy of bone and soft tissue lesions].
Kitagawa A; Saeki M; Imamura K; Ohashi K; Ishikawa T; Nakajima H; Takagi M
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1017-24. PubMed ID: 8587841
[TBL] [Abstract][Full Text] [Related]
3. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
5. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.
Negendank WG; Crowley MG; Ryan JR; Keller NA; Evelhoch JL
Radiology; 1989 Oct; 173(1):181-8. PubMed ID: 2675183
[TBL] [Abstract][Full Text] [Related]
6. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
7. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma.
Vaupel P; Okunieff P; Kallinowski F; Neuringer LJ
Radiat Res; 1989 Dec; 120(3):477-93. PubMed ID: 2594969
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
9. Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy.
Younkin DP; Delivoria-Papadopoulos M; Leonard JC; Subramanian VH; Eleff S; Leigh JS; Chance B
Ann Neurol; 1984 Nov; 16(5):581-6. PubMed ID: 6508240
[TBL] [Abstract][Full Text] [Related]
10. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of radioisotope diagnosis of skeletal tumors].
Knysh IT; Mechev DS; Tolstopiatov BA
Vopr Onkol; 1971; 17(4):29-36. PubMed ID: 4935522
[No Abstract] [Full Text] [Related]
13. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
[TBL] [Abstract][Full Text] [Related]
14. The effects of age on phosphatic metabolites of the human cornea.
Lass JH; Greiner JV; Merchant TE; Glonek T
Cornea; 1995 Jan; 14(1):89-94. PubMed ID: 7712743
[TBL] [Abstract][Full Text] [Related]
15. New approaches in the diagnosis of small-cell round tumors of bone and soft tissue.
Petrov SV; Machado I; Boulytcheva IV; Noguera R; Pellin A; Bacchini P; Bertoni F; Llombart-Bosch A
Arkh Patol; 2009; 71(1):34-40. PubMed ID: 19514357
[TBL] [Abstract][Full Text] [Related]
16. [In vivo 31 phosphorus spectroscopy of tumors: pre-, intra- and post-therapy].
Semmler W; Gademann G; Bachert-Baumann P; Bier V; Zabel HJ; Lorenz WJ; von Kaick G
Rofo; 1988 Oct; 149(4):369-77. PubMed ID: 2845503
[TBL] [Abstract][Full Text] [Related]
17. In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy.
Möller HE; Vermathen P; Rummeny E; Wörtler K; Wuisman P; Rössner A; Wörmann B; Ritter J; Peters PE
NMR Biomed; 1996 Dec; 9(8):347-58. PubMed ID: 9176889
[TBL] [Abstract][Full Text] [Related]
18. [The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium].
Schindler R; Krahe T; Neubauer S; Hillenbrand H; Entzeroth C; Horn M; Lackner K; Ertl G
Rofo; 1992 Nov; 157(5):452-7. PubMed ID: 1421185
[TBL] [Abstract][Full Text] [Related]
19. Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.
Hoekstra HJ; Boeve WJ; Kamman RL; Mooyaart EL
Ann Surg Oncol; 1994 Nov; 1(6):504-11. PubMed ID: 7850556
[TBL] [Abstract][Full Text] [Related]
20. [Malignant, primary bone tumors. Experience report of the Dutch Committee for Bone Tumors].
von Ronnen JR
Arch Chir Neerl; 1965; 17(1):23-54. PubMed ID: 5216012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
